Abpro (ABP)
Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Abpro Analyst Rating
View moreForecast & Rating
Oct 21, 2025Price forecast
$60.0011394.26%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Aug 26 at 07:14 AM
Key facts: KKR & Co Inc finalist for AB Ports; buys Ci FLAVORS
- PUBT · Jul 3 at 06:07 AM
Nocivelli ABP updates financial calendar for 2026-2027 events
- TradingView · Jun 4 at 09:13 PM
Abpro Holdings Received Notice of Delisting
- Price Alert · Feb 20 at 07:00 PM
US Stock Movement Update: Abits surged 163.29%, Rackspace Tech rose 64.49%, Twin Vee PowerCats fell 54.59%
- Price Alert · Feb 17 at 06:17 PM
U.S. stock market midday update: Abpro down 14% with increased trading volume, market sentiment fluctuates significantly, future trends need to be monitored
